239 related articles for article (PubMed ID: 25918236)
1. DLK1 Regulates Whole-Body Glucose Metabolism: A Negative Feedback Regulation of the Osteocalcin-Insulin Loop.
Abdallah BM; Ditzel N; Laborda J; Karsenty G; Kassem M
Diabetes; 2015 Sep; 64(9):3069-80. PubMed ID: 25918236
[TBL] [Abstract][Full Text] [Related]
2. Evidence for Osteocalcin Binding and Activation of GPRC6A in β-Cells.
Pi M; Kapoor K; Ye R; Nishimoto SK; Smith JC; Baudry J; Quarles LD
Endocrinology; 2016 May; 157(5):1866-80. PubMed ID: 27007074
[TBL] [Abstract][Full Text] [Related]
3. The endocrine role of the skeleton: background and clinical evidence.
Schwetz V; Pieber T; Obermayer-Pietsch B
Eur J Endocrinol; 2012 Jun; 166(6):959-67. PubMed ID: 22436399
[TBL] [Abstract][Full Text] [Related]
4. Proprotein convertase furin regulates osteocalcin and bone endocrine function.
Al Rifai O; Chow J; Lacombe J; Julien C; Faubert D; Susan-Resiga D; Essalmani R; Creemers JW; Seidah NG; Ferron M
J Clin Invest; 2017 Nov; 127(11):4104-4117. PubMed ID: 28972540
[TBL] [Abstract][Full Text] [Related]
5. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition.
Fulzele K; Riddle RC; DiGirolamo DJ; Cao X; Wan C; Chen D; Faugere MC; Aja S; Hussain MA; Brüning JC; Clemens TL
Cell; 2010 Jul; 142(2):309-19. PubMed ID: 20655471
[TBL] [Abstract][Full Text] [Related]
6. Osteocalcin-dependent regulation of glucose metabolism and fertility: Skeletal implications for the development of insulin resistance.
Tangseefa P; Martin SK; Fitter S; Baldock PA; Proud CG; Zannettino ACW
J Cell Physiol; 2018 May; 233(5):3769-3783. PubMed ID: 28834550
[TBL] [Abstract][Full Text] [Related]
7. GPRC6A mediates responses to osteocalcin in β-cells in vitro and pancreas in vivo.
Pi M; Wu Y; Quarles LD
J Bone Miner Res; 2011 Jul; 26(7):1680-3. PubMed ID: 21425331
[TBL] [Abstract][Full Text] [Related]
8. Endocrine regulation of energy metabolism by the skeleton.
Lee NK; Sowa H; Hinoi E; Ferron M; Ahn JD; Confavreux C; Dacquin R; Mee PJ; McKee MD; Jung DY; Zhang Z; Kim JK; Mauvais-Jarvis F; Ducy P; Karsenty G
Cell; 2007 Aug; 130(3):456-69. PubMed ID: 17693256
[TBL] [Abstract][Full Text] [Related]
9. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.
Ueland T; Fougner SL; Godang K; Lekva T; Schurgers LJ; Scholz H; Halvorsen B; Schreiner T; Aukrust P; Bollerslev J
J Clin Endocrinol Metab; 2010 Jan; 95(1):361-8. PubMed ID: 19880791
[TBL] [Abstract][Full Text] [Related]
10. Association between osteocalcin gamma-carboxylation and insulin resistance in overweight and obese postmenopausal women.
Bonneau J; Ferland G; Karelis AD; Doucet É; Faraj M; Rabasa-Lhoret R; Ferron M
J Diabetes Complications; 2017 Jun; 31(6):1027-1034. PubMed ID: 28242268
[TBL] [Abstract][Full Text] [Related]
11. Serum osteocalcin is associated with improved metabolic state via adiponectin in females versus testosterone in males. Gender specific nature of the bone-energy homeostasis axis.
Buday B; Pach FP; Literati-Nagy B; Vitai M; Vecsei Z; Koranyi L
Bone; 2013 Nov; 57(1):98-104. PubMed ID: 23886839
[TBL] [Abstract][Full Text] [Related]
12. Osteocalcin, energy and glucose metabolism.
Zanatta LC; Boguszewski CL; Borba VZ; Kulak CA
Arq Bras Endocrinol Metabol; 2014 Jul; 58(5):444-51. PubMed ID: 25166034
[TBL] [Abstract][Full Text] [Related]
13. The osteoblast: an insulin target cell controlling glucose homeostasis.
Clemens TL; Karsenty G
J Bone Miner Res; 2011 Apr; 26(4):677-80. PubMed ID: 21433069
[TBL] [Abstract][Full Text] [Related]
14. Lack of Lrp5 Signaling in Osteoblasts Sensitizes Male Mice to Diet-Induced Disturbances in Glucose Metabolism.
Kim SP; Frey JL; Li Z; Goh BC; Riddle RC
Endocrinology; 2017 Nov; 158(11):3805-3816. PubMed ID: 28938444
[TBL] [Abstract][Full Text] [Related]
15. Osteoblast-specific expression of Fra-2/AP-1 controls adiponectin and osteocalcin expression and affects metabolism.
Bozec A; Bakiri L; Jimenez M; Rosen ED; Catalá-Lehnen P; Schinke T; Schett G; Amling M; Wagner EF
J Cell Sci; 2013 Dec; 126(Pt 23):5432-40. PubMed ID: 24046454
[TBL] [Abstract][Full Text] [Related]
16. [Bone remodeling and glucose/lipid metabolism].
Yoshizawa T
Clin Calcium; 2011 May; 21(5):709-14. PubMed ID: 21532121
[TBL] [Abstract][Full Text] [Related]
17. New insights into the biology of osteocalcin.
Zoch ML; Clemens TL; Riddle RC
Bone; 2016 Jan; 82():42-9. PubMed ID: 26055108
[TBL] [Abstract][Full Text] [Related]
18. Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism.
Yoshikawa Y; Kode A; Xu L; Mosialou I; Silva BC; Ferron M; Clemens TL; Economides AN; Kousteni S
J Bone Miner Res; 2011 Sep; 26(9):2012-25. PubMed ID: 21557308
[TBL] [Abstract][Full Text] [Related]
19. DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.
Abdallah BM; Ditzel N; Mahmood A; Isa A; Traustadottir GA; Schilling AF; Ruiz-Hidalgo MJ; Laborda J; Amling M; Kassem M
J Bone Miner Res; 2011 Jul; 26(7):1457-71. PubMed ID: 21308776
[TBL] [Abstract][Full Text] [Related]
20. Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) inversely regulate OPG gene expression in dependence of the osteoblastic phenotype.
Varga F; Spitzer S; Klaushofer K
Calcif Tissue Int; 2004 Apr; 74(4):382-7. PubMed ID: 15255076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
